Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
28.61
+2.61 (10.04%)
At close: Dec 9, 2025
TEVJF Market Cap
TEVJF has a market cap or net worth of $36.41 billion as of December 24, 2025. Its market cap has increased by 82.36% in one year.
Market Cap
36.41B
Enterprise Value
51.31B
Revenue
16.78B
Ranking
n/a
PE Ratio
51.07
Stock Price
$28.61
Market Cap Chart
Since June 26, 1992, TEVJF's market cap has increased from 588.88M to 36.41B, an increase of 6,083.68%. That is a compound annual growth rate of 13.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 36.41B | 45.62% |
| Dec 31, 2024 | 25.01B | 113.68% |
| Dec 29, 2023 | 11.70B | 15.54% |
| Dec 30, 2022 | 10.13B | 14.65% |
| Dec 31, 2021 | 8.84B | -16.46% |
| Dec 31, 2020 | 10.58B | -1.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 722.39M |
| Elite Pharmaceuticals | 515.15M |
| Northwest Biotherapeutics | 401.29M |
| American Oncology Network | 394.40M |
| CytoDyn | 357.58M |
| Silence Therapeutics | 304.66M |
| Nika Pharmaceuticals | 291.10M |